Minireviews
Copyright ©The Author(s) 2023.
World J Gastroenterol. Apr 7, 2023; 29(13): 1969-1981
Published online Apr 7, 2023. doi: 10.3748/wjg.v29.i13.1969
Table 1 Summary of key contemporary series of liver transplantation for cholangiocarcinoma
Ref.
Country
Design
Tumour anatomical subtype
Treatments (s)
Total patients (n)
Median follow-up/yr (range)
Outcomes (5-year)1
Overall survival (%)
Disease free survival (%)
Graft survival (%)
Azad et al[28], 2020United StatesRetrospective, single centrePerihilarNeoadjuvant chemo-radiotherapy and LTDe novo: 148, PSC: 228-De novo: 58 KM, PSC: 74 KMDe novo: 55 KM, PSC: 78 KM-
Darwish Murad et al[36], 2012United StatesRetrospective, multi-centrePerihilarNeoadjuvant chemo-radiotherapy and LT2872.5 (0.1-17.8)53 KM65 KM60 KM
Hidalgo et al[37], 2008United KingdomRetrospective, single centrePerihilarLT121.8141 KM--
Robles et al[38], 2004SpainRetrospective, multi-centrePerihilarLT36-6447-
Ethun et al[14], 2018United StatesRetrospective, multi-centrePerihilarNeoadjuvant chemo-radiotherapy and LT704.83 (0.025-10.6)64 KM24 KM-
Krasnodębski et al[47], 2020PolandRetrospective, multi-centreIntrahepaticLT8302528.6-
Lee et al[48], 2018United StatesRetrospective, single centreIntrahepaticNeoadjuvant TARE/TACE/RFA and LT17Mean 4.251.970.6-
Sapisochin et al[50], 2014SpainRetrospective, multi-centreIntrahepaticNeoadjuvant ethanol injection/TACE/RFA and LT274.99 (0.97-11.9)5136-
Sapisochin et al[51], 2016InternationalRetrospective, multi-centreIntrahepatic- early1 and advancedNeoadjuvant ethanol injection/TACE/RFA and LTEarly1-15, Advanced-33Early-4.78, Advanced-2.06Early-65, Advanced-45Early-86.7, Advanced-48.5-
Hue et al[54], 2021United StatesRetrospective, multi-centreIntrahepaticNeoadjuvant chemo-radiation and LT743.933 KM--
Lunsford et al[55], 2018United StatesProspective, single centreIntrahepaticNeoadjuvant chemotherapy and LT63 (2.42-4.25)83.350100
Wong et al[56], 2019United StatesProspective, single centreIntrahepaticNeoadjuvant chemotherapy and TACE and LT51.848060-